新元科技(300472.SZ)回購註銷322.46萬股業績補償股份
格隆匯8月15日丨新元科技(300472.SZ)公佈,此次回購註銷業績補償股份數量為約322.46萬股,其中王展應補償股份數量約247.91萬股、北京創致天下投資管理中心(有限合夥)(“創致天下”)應補償股份數量為約74.55萬股,均為有限售條件流通股,佔回購前公司總股本約2.12億的1.52%。
此次業績補償的股份約322.46萬股由公司以1元總價回購並註銷。此次回購的股份已於2019年8月14日在中國證券登記結算有限責任公司深圳分公司完成註銷手續。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.